Item 8.01. Other Events.

On December 23, 2008, Teva Pharmaceutical Industries Limited ("Teva") issued a press release announcing the completion of the merger of Barr Pharmaceuticals, Inc. ("Barr") with a wholly-owned subsidiary of Teva. The merger was approved by the shareholders of Barr at a special meeting held on November 21, 2008. As a result of the merger, Barr became a privately-held company, wholly-owned by Teva. Shares of Barr's common stock, which prior to the merger traded on the New York Stock Exchange, are in the process of being delisted from trading. The foregoing description of the press release does not purport to be complete and is qualified in its entirety by reference to the press release, which is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein reference.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

99.1 Press Release, dated December 23, 2008, issued by Teva Pharmaceutical Industries Limited